Preparation and in vitro assessment of economic bio-scaffolds modified with wollastonite (CaSiO3)
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Bone Tissue Engineering Materials · Endodontics and Root Canal Treatments · Calcium Carbonate Crystallization and Inhibition
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (84)
Show source-provided references
1. Bioactive bone cement: comparsion of apatite and wollastonite containing glass-ceramic,hydroxyapatite and β-tricalcium phosphate filler on bone-bonding strength10.1002/(SICI)1097-4636(199811)42:2<223::AID-JBM7>3.0.CO;2-R ↗
2. Natural pseudowol- lastonite: crystal structure, associated minerals, and geological context10.1016/j.lithos.2011.12.010 ↗
3. Green synthesis of calcium silicate bioceramic powders10.1016/j.ceramint.2014.12.112 ↗
4. Synthesis of nanocrystalline wollastonite powders by citrate nitrate gel combustion method10.1016/j.matchemphys.2008.11.066 ↗
5. Synthesis and characterization of monazite-type Sr: LaPO4 prepared through coprecipitation10.1016/j.jeurceramsoc.2005.03.004 ↗
6. Synthesis of wollastonite powders by combustion method: role of amount of fuel
7. Bioactive nanocrystalline wollastonite synthesized by sol–gel combustion method by using eggshell waste as calcium source10.1007/s12034-014-0646-5 ↗
8. Microwave synthesis of wollastonite powder from eggshells10.1016/j.jeurceramsoc.2011.02.026 ↗
9. Synthesis and microwave dielectric properties of CaSiO3 nanopowder by the sol-gel process10.1016/j.ceramint.2007.05.001 ↗
10. The influence of the size and aspect ratio of anisotropic, porous CaCO3 particles on their uptake by cells
11. Heat-driven size reduction of biodegradable polyelectrolyte multilayer hollow capsules assembled on CaCO3 template10.1016/j.colsurfb.2018.06.033 ↗
12. Influence of heat treatment on loading of polymeric multilayer microcapsules with RhodamineB
13. Stability and cell uptake of calcium carbonate templated insulin microparticles10.1016/j.actbio.2013.11.011 ↗
14. Geopolymer with hierarchically meso-/macroporous structures from reactive emulsion templating10.1111/jace.12724 ↗
15. Synthesis of porous hierarchical geopolymer monoliths by ice-templating, Microporous Mesoporous Mater., Synthesis of porous hierarchical geopolymer monoliths by ice-templating10.1016/j.micromeso.2015.05.043 ↗
16. High strength metakaolinbased geopolymer foams with variable macroporous structure10.1016/j.jeurceramsoc.2016.06.045 ↗
17. High-porosity geopolymer foams with tailored porosity for thermal insulation and wastewater treatment10.1557/jmr.2017.127 ↗
18. Direct ink writing of geopolymeric inks10.1016/j.jeurceramsoc.2017.01.030 ↗
19. Highly porous mullite ceramics from engineered alkali activated suspensions10.1111/jace.15327 ↗
20. Mechanism of apatite formation on wollastonite coatings in simulated body fluids10.1016/j.biomaterials.2003.08.024 ↗
21. 2003 · 1
22. Bioactivity and cell compatibility of β-wollastonite derived from rice husk ash and limestone10.3390/ma10101188 ↗
23. MAS -NMR studies of geopolymers heat treated for applications in biomaterials field10.1007/s10853-006-0524-7 ↗
24. Derrien · J. Therm. Anal. · 2004 · 75 · 93710.1023/B:JTAN.0000027187.14921.86 ↗
25. Benefication of Mardin-Mazidagi (Turkey) calcareous phosphate rock using dilute acetic acid solutions10.1016/j.cej.2006.06.005 ↗
26. The geology of Egypt
27. Origin of late cretaceous phosphorites in Egypt10.1016/j.cretres.2004.12.004 ↗
28. Solutions able to reproduce in vivo surface-structure changes in bioactive glass-ceramic A-W10.1002/jbm.820240607 ↗
29. Fabrication and characterization of bioactive calcium silicate microspheres for drug delivery10.1016/j.ceramint.2013.09.106 ↗
30. How useful is SBF in predicting in vivo bone bioactivity?10.1016/j.biomaterials.2006.01.017 ↗
31. Chitosan–sodium alginate nanoparticles as submicroscopic reservoirs for ocular delivery: formulation, optimisation and in vitro characterisation
32. Preparation and characterization of polycaprolactone/forsterite nanocomposite porous scaffolds designed for bone tissue regeneration
33. An Antibiotic assay by the agar well diffusion method
34. The nephelometer: an instrument for estimating the number of bacteria in suspensions used for calculating the opsonic index and for vaccines10.1001/jama.1907.25320140022001f ↗
35. Using digital photography to implement the McFarland method10.1098/rsif.2011.0809 ↗
36. Antimicrobial activity of essential oils from plants against selected pathogenic and saprophytic microorganisms10.4315/0362-028X-64.7.1019 ↗
37. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays10.1016/0022-1759(83)90303-4 ↗
38. ASTM C-20; Standard Test Methods for Apparent Porosity, Water Absorption, Apparent Specific Gravity, and Bulk Density of Burned Refractory Brick and Shapes by Boiling Water.
39. DIN EN ISO 6872:1999 Dental Ceramic (ISO 6872:1995 Including Amendment 1:1997); English Version of DIN EN ISO 6872.
40. Strontium ranelate for preventing and treating postmenopausal osteoporosis
41. Sr-substituted hydroxyapatites for osteoporotic bone replacement10.1016/j.actbio.2007.05.006 ↗
42. In vivo and clinical application of strontium-enriched biomaterials for bone regeneration: a systematic review10.1302/2046-3758.66.BJR-2016-0311.R1 ↗
43. Strontium and strontium ranelate: historical review of some of their functions10.1016/j.msec.2017.05.042 ↗
44. Electrophoretic deposition of spray-dried Sr-containing mesoporous bioactive glass spheres on glass–ceramic scaffolds for bone tissue regeneration10.1007/s10853-017-1026-5 ↗
45. A review of the latest insights into the mechanism of action of strontium in bone
46. Postgrad. Med., zinc deficiency: a cause of growth retardation?10.1080/00325481.1964.11695018 ↗
47. Zinc homeostasis and signaling in health and diseases: zinc signaling10.1007/s00775-011-0797-4 ↗
48. Clinical, biochemical and nutritional spectrum of zinc deficiency in human subjects: an update10.1111/j.1753-4887.1983.tb07155.x ↗
49. Influence of copper (II) complex on the activity of selected oxidative enzymes
50. In vitro study of the effects of copper ion on osteoclastic resorption in various dental mineralized tissues
51. Impaired mechanical strength of bone in experimental copper Deficiency10.1159/000177774 ↗
52. A technique for the tensile testing of demineralised bone10.1016/0021-9290(93)90365-L ↗
53. Noor · 2012 · 1
54. a new tool for biologists10.1038/281337a0 ↗
55. Two-dimensional (2D) pulsed electron paramagnetic resonance study of VO(2þ)-triphosphate interactions: evidence for tridentate triphosphate coordination, and relevance to bone uptake and insulin enhancement by vanadium pharmaceuticals10.1021/ja011104s ↗
56. Ameliorative effect of an oxovanadium (IV) complex against oxidative stress and nephrotoxicity induced by cisplatin
57. The chemistry and biochemistry of vanadium and the biological activities exerted by vanadium compounds10.1021/cr020607t ↗
58. Local vanadium release from a calcium sulfate carrier accelerates fracture healing10.1002/jor.22570 ↗
59. Osteogenic activity of vanadyl (IV)-ascorbate complex: evaluation of its mechanism of action10.1016/j.biocel.2005.12.007 ↗
60. Perspectives for vanadium in health issues10.4155/fmc.15.187 ↗
61. Vanadium and bone development: putative signaling pathways10.1139/y06-022 ↗
62. Enzyme interactions with labile oxovanadates and other oxometalates
63. The chemistry of vanadium in aqueous and nonaqueous solution
64. U ber die wechselwirrkung des vanadyl (IV)- kations mit calcium hydroxylapatit10.1515/znb-1992-0316 ↗
65. Anabolic effects of insulin on bone suggest a role for chromium picolinate in preservation of bone density10.1016/0306-9877(95)90112-4 ↗
66. Movasaghi · J. Appl. Spectrosc. Rev. · 2007 · 42 · 49310.1080/05704920701551530 ↗
67. Biological hydroxyapatite obtained from fish bones10.1016/j.msec.2011.11.021 ↗
68. In vitro and in vivo study of naturally derived alginate/hydroxyapatite bio composite scaffolds10.1016/j.ijbiomac.2020.10.014 ↗
69. A modified wet chemical synthesis of Wollastonite ceramic nanopowders and their characterizations10.1016/j.ceramint.2020.02.026 ↗
70. α-wollastonite crystallization at low temperature10.1016/j.ceramint.2019.11.143 ↗
71. In-situ growth of mullite whiskers and their effect on the microstructure and properties of porous mullite ceramics with an open/closed pore structure10.1016/j.jeurceramsoc.2021.09.045 ↗
72. Growth mechanism and growth habit of oxide crystal10.1016/S0022-0248(99)00076-7 ↗
73. Rapid formation of hydroxyapatite nanostructures by microwave irradiations10.1016/j.cplett.2004.08.094 ↗
74. Hench · J. Biomed. Mater. Res., Part A · 2007 · 80 · 565
75. H. Bioactivity and cell compatibility of β-wollastonite derived from rice husk ash and limestone10.3390/ma10101188 ↗
76. Bone-like forming ability of apatite-wollastonite glass ceramic10.1016/j.jeurceramsoc.2011.03.007 ↗
77. Ratner · 2004
78. Cyclic silicate active site and stereochemical match for apatite nucleation on pseudo wollastonite bioceramic-bone interfaces10.1016/j.biomaterials.2005.02.037 ↗
79. In vitro bioactivity and degradation behaviour of β-wollastonite derived from natural waste Srinath10.1016/j.msec.2018.12.101 ↗
80. In vitro degradation of porous degradable and bioactive PHBV/wollastonite composite scaffolds10.1016/j.polymdegradstab.2004.09.001 ↗
81. Synthesis, characterization and antibacterial activity of cobalt doped cerium oxide (CeO2: Co) nanoparticles by using the hydrothermal method10.1016/j.jmrt.2017.12.005 ↗
82. Cytotoxicity of CeO2 nanoparticles for Escherichia coli. Physico-chemical insight of the cytotoxicity mechanism10.1021/es060999b ↗
83. Zinc oxide nanoparticles: a promising nanomaterial for biomedical applications
84. Mechanism of photogenerated reactive oxygen species and correlation with the antibacterial properties of engineered metal-oxide nanoparticles10.1021/nn300934k ↗